NYSE · CIK 0001518621
ORC Orchid Island Capital, Inc.
Insider trading from SEC Form 4. Last filing 12 d ago. Close $5.08 on Oct 9, 2026, +2% from the 52-week low and -30% from the high.
Orchid Island Capital, Inc. (ORC) has 58 SEC Form 4 filings on file from 6 insiders, the latest filed on Oct 1, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
1 open-market trade has been scored at ORC. The newest: W Coleman Bitting (director) bought $309 of stock on Aug 29, 2023, filed Apr 1, 2025, scored 10 (weak).
ORC closed at $5.08 on Oct 9, 2026, 2% above its 52-week low and 30% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Orchid Island Capital, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | W Coleman Bitting director buy | $309 39 shares | +1% | - |
Transactions
The newest 50 of 105 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | W Coleman Bitting director | AGrant or award Deferred Stock Unitsderivative | +5,755 | $0.00 | $0 | 59,630 | 12 d ago |
| Oct 1, 2026 | Paula Morabito director | AGrant or award Deferred Stock Unitsderivative | +5,755 | $0.00 | $0 | 61,441 | 12 d ago |
| Sep 30, 2026 | Ava L Parker director | AGrant or award Deferred Stock Unitsderivative | +2,183 | $5.77 | $13k | 128,169 | 12 d ago |
| Oct 1, 2026 | Frank P Filipps director | AGrant or award Deferred Stock Unitsderivative | +5,755 | $0.00 | $0 | 59,630 | 12 d ago |
| Oct 1, 2026 | Ava L Parker director | AGrant or award Deferred Stock Unitsderivative | +5,755 | $0.00 | $0 | 133,924 | 12 d ago |
| Sep 25, 2026 | G Hunter Haas IV Chief Financial Officer | MOption exercise Common Stock | +1,189 | $0.00 | $0 | 138,711 | 18 d ago |
| Sep 25, 2026 | Robert E Cauley Chief Executive Officer | MOption exercise Common Stock | +1,276 | $0.00 | $0 | 228,260 | 18 d ago |
| Sep 25, 2026 | G Hunter Haas IV Chief Financial Officer | FTax withholding Common Stock | -468 | $5.77 | $2,700 | 138,243 | 18 d ago |
| Sep 25, 2026 | Robert E Cauley Chief Executive Officer | MOption exercise Performance Unitsderivative | -1,276 | $0.00 | $0 | 125,719 | 18 d ago |
| Sep 25, 2026 | G Hunter Haas IV Chief Financial Officer | MOption exercise Performance Unitsderivative | -1,189 | $0.00 | $0 | 96,751 | 18 d ago |
| Jul 1, 2026 | Frank P Filipps director | AGrant or award Deferred Stock Unitsderivative | +3,586 | $0.00 | $0 | 53,875 | Jul 1, 2026 |
| Jul 1, 2026 | W Coleman Bitting director | AGrant or award Deferred Stock Unitsderivative | +3,586 | $0.00 | $0 | 53,875 | Jul 1, 2026 |
| Jun 26, 2026 | Robert E Cauley Chief Executive Officer | MOption exercise Common Stock | +3,694 | $0.00 | $0 | 226,984 | Jun 29, 2026 |
| Jun 26, 2026 | G Hunter Haas IV Chief Financial Officer | MOption exercise Common Stock | +3,031 | $0.00 | $0 | 138,715 | Jun 29, 2026 |
| Jun 26, 2026 | G Hunter Haas IV Chief Financial Officer | FTax withholding Common Stock | -1,193 | $6.86 | $8,184 | 137,522 | Jun 29, 2026 |
| Jun 26, 2026 | Robert E Cauley Chief Executive Officer | MOption exercise Performance Unitsderivative | -3,694 | $0.00 | $0 | 126,995 | Jun 29, 2026 |
| Jun 26, 2026 | G Hunter Haas IV Chief Financial Officer | MOption exercise Performance Unitsderivative | -3,032 | $0.00 | $0 | 97,940 | Jun 29, 2026 |
| May 29, 2026 | Ava L Parker director | AGrant or award Deferred Stock Unitsderivative | +1,660 | $6.95 | $12k | 117,075 | Jun 1, 2026 |
| Apr 30, 2026 | Ava L Parker director | AGrant or award Deferred Stock Unitsderivative | +1,877 | $7.03 | $13k | 115,415 | May 5, 2026 |
| Apr 1, 2026 | W Coleman Bitting director | AGrant or award Deferred Stock Unitsderivative | +3,561 | $0.00 | $0 | 50,289 | Apr 1, 2026 |
| Apr 1, 2026 | Frank P Filipps director | AGrant or award Deferred Stock Unitsderivative | +3,561 | $0.00 | $0 | 50,289 | Apr 1, 2026 |
| Apr 1, 2026 | Paula Morabito director | AGrant or award Deferred Stock Unitsderivative | +3,561 | $0.00 | $0 | 52,100 | Apr 1, 2026 |
| Mar 30, 2026 | Ava L Parker director | AGrant or award Deferred Stock Unitsderivative | +1,877 | $6.91 | $13k | 109,977 | Apr 1, 2026 |
| Apr 1, 2026 | Ava L Parker director | AGrant or award Deferred Stock Unitsderivative | +3,561 | $0.00 | $0 | 113,538 | Apr 1, 2026 |
| Mar 26, 2026 | Robert E Cauley Chief Executive Officer | MOption exercise Common Stock | +3,694 | $0.00 | $0 | 223,290 | Mar 27, 2026 |
| Mar 26, 2026 | G Hunter Haas IV Chief Financial Officer | MOption exercise Common Stock | +3,031 | $0.00 | $0 | 136,817 | Mar 27, 2026 |
| Mar 26, 2026 | Robert E Cauley Chief Executive Officer | MOption exercise Performance Unitsderivative | -3,694 | $0.00 | $0 | 130,690 | Mar 27, 2026 |
| Mar 26, 2026 | G Hunter Haas IV Chief Financial Officer | FTax withholding Common Stock | -1,133 | $7.15 | $8,101 | 135,684 | Mar 27, 2026 |
| Mar 26, 2026 | G Hunter Haas IV Chief Financial Officer | MOption exercise Performance Unitsderivative | -3,032 | $0.00 | $0 | 100,972 | Mar 27, 2026 |
| Mar 23, 2026 | G Hunter Haas IV Chief Financial Officer | AGrant or award Common Stock | +93,184 | $0.00 | $0 | 170,682 | Mar 23, 2026 |
| Mar 23, 2026 | Robert E Cauley Chief Executive Officer | AGrant or award Common Stock | +121,891 | $0.00 | $0 | 269,386 | Mar 23, 2026 |
| Mar 23, 2026 | G Hunter Haas IV Chief Financial Officer | FTax withholding Common Stock | -36,896 | $6.82 | $252k | 133,786 | Mar 23, 2026 |
| Mar 23, 2026 | Robert E Cauley Chief Executive Officer | FTax withholding Common Stock | -49,790 | $6.82 | $340k | 219,596 | Mar 23, 2026 |
| Mar 23, 2026 | Robert E Cauley Chief Executive Officer | AGrant or award Performance Unitsderivative | -121,891 | $0.00 | $0 | 134,384 | Mar 23, 2026 |
| Mar 23, 2026 | G Hunter Haas IV Chief Financial Officer | AGrant or award Performance Unitsderivative | -93,184 | $0.00 | $0 | 104,003 | Mar 23, 2026 |
| Feb 27, 2026 | Ava L Parker director | AGrant or award Deferred Stock Unitsderivative | +1,680 | $7.60 | $13k | 108,100 | Mar 2, 2026 |
| Jan 30, 2026 | Ava L Parker director | AGrant or award Deferred Stock Unitsderivative | +1,559 | $7.80 | $12k | 106,420 | Feb 2, 2026 |
| Jan 2, 2026 | W Coleman Bitting director | AGrant or award Deferred Stock Unitsderivative | +3,472 | $0.00 | $0 | 46,728 | Jan 2, 2026 |
| Jan 2, 2026 | Frank P Filipps director | AGrant or award Deferred Stock Unitsderivative | +3,472 | $0.00 | $0 | 46,728 | Jan 2, 2026 |
| Jan 2, 2026 | Paula Morabito director | AGrant or award Deferred Stock Unitsderivative | +3,472 | $0.00 | $0 | 48,539 | Jan 2, 2026 |
| Dec 30, 2025 | Ava L Parker director | AGrant or award Deferred Stock Unitsderivative | +1,644 | $7.28 | $12k | 101,389 | Jan 2, 2026 |
| Jan 2, 2026 | Ava L Parker director | AGrant or award Deferred Stock Unitsderivative | +3,472 | $0.00 | $0 | 104,861 | Jan 2, 2026 |
| Dec 26, 2025 | Robert E Cauley Chief Executive Officer | MOption exercise Common Stock | +3,694 | $0.00 | $0 | 148,248 | Dec 29, 2025 |
| Dec 26, 2025 | G Hunter Haas IV Chief Financial Officer | MOption exercise Common Stock | +3,031 | $0.00 | $0 | 78,631 | Dec 29, 2025 |
| Dec 26, 2025 | Robert E Cauley Chief Executive Officer | FTax withholding Common Stock | -753 | $7.35 | $5,535 | 147,495 | Dec 29, 2025 |
| Dec 26, 2025 | G Hunter Haas IV Chief Financial Officer | FTax withholding Common Stock | -1,133 | $7.35 | $8,328 | 77,498 | Dec 29, 2025 |
| Dec 26, 2025 | Robert E Cauley Chief Executive Officer | MOption exercise Performance Unitsderivative | -3,694 | $0.00 | $0 | 12,493 | Dec 29, 2025 |
| Dec 26, 2025 | G Hunter Haas IV Chief Financial Officer | MOption exercise Performance Unitsderivative | -3,032 | $0.00 | $0 | 10,819 | Dec 29, 2025 |
| Nov 28, 2025 | Ava L Parker director | AGrant or award Deferred Stock Unitsderivative | +1,615 | $7.29 | $12k | 99,745 | Dec 1, 2025 |
| Oct 31, 2025 | Ava L Parker director | AGrant or award Deferred Stock Unitsderivative | +1,494 | $7.31 | $11k | 98,130 | Nov 3, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- W Coleman Bittingdirector
- Robert E CauleyChief Executive Officer
- Frank P Filippsdirector
- G Hunter Haas IVChief Financial Officer
- Paula Morabitodirector
- Ava L Parkerdirector
Questions about ORC
Answered from the filings on this page, as of the latest one.
Are insiders buying ORC?
No. In the last 90 days no insider at Orchid Island Capital, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade ORC on the open market?
W Coleman Bitting (director) bought $309 of ORC on Aug 29, 2023 and filed the Form 4 on Apr 1, 2025. InsiderTell scored 10 (weak).
How many insiders file Form 4 at Orchid Island Capital, Inc.?
6 people have filed a Form 4 at Orchid Island Capital, Inc., among them W Coleman Bitting (director), Robert E Cauley (Chief Executive Officer), Frank P Filipps (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.